Akso Health (AHG) Receivables (2019 - 2026)

Akso Health (AHG) has reported Receivables for 8 consecutive years, with $193.8 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 8.26% year-over-year to $193.8 million; the trailing twelve-month figure through Mar 2026 stood at $193.8 million (down 8.26% YoY), and the FY2026 full-year result was $193.8 million, down 8.26% from the prior year.
• Receivables advanced to $193.8 million in Q1 2026 per AHG's latest filing, from $10.8 million in the prior quarter.
• Across five years, Receivables topped out at $211.3 million in Q1 2025 and bottomed at $7.8 million in Q3 2023.
• Historically, Receivables has averaged $58.1 million across 5 years, with a median of $10.8 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Receivables sank 76.7% in 2023, then surged 2618.63% in 2025.
• Over 5 years, Receivables stood at $33.4 million in 2022, then tumbled by 76.7% to $7.8 million in 2023, then increased by 4.61% to $8.1 million in 2024, then jumped by 33.36% to $10.8 million in 2025, then jumped by 1687.9% to $193.8 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $193.8 million, $10.8 million, and $211.3 million for Q1 2026, Q3 2025, and Q1 2025 respectively.